Research

Energy balance

Bariatric surgery still outperforms pharmacotherapy in terms of absolute weight loss magnitude and durability, with surgery yielding approximately five times more weight loss in real-world cohorts.

While incretin drugs are powerful, bariatric surgery still achieves greater weight loss on average (25-35% vs 15-22%). If your goal is maximum possible weight loss and you are a surgical candidate, surgery may still be the most effective option. However, if you fear surgery or have contraindications, polyagonists offer a highly effective, non-surgical path to significant weight loss.

GoodQualifiesHIGH confidence
Recent retrospective head-to-head studies suggest that, while the newest incretin polyagonists can approach the efficacy of bariatric surgery for diabetes and obesity management, surgical interventions (such as sleeve gastrectomy and gastric bypass) still outperform pharmacotherapy in terms of absolute weight loss. For example, bariatric procedures were associated with approximately five times more weight loss than GLP-1 RA injections in real-world cohorts.
Rohit Jacob Manoj et al. · World Journal of Gastrointestinal Pathophysiology · 2026

Why this rating

Based on retrospective cohort studies and meta-analyses cited.

Source

Incretin polyagonists as an alternative to bariatric surgery to manage obesity

Rohit Jacob Manoj et al. · World Journal of Gastrointestinal Pathophysiology · 2026

DOI 10.4291/wjgp.v17.i1.118132

narrative_review
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →